JCDecaux : Q1 2026 – Business review

Please find attached our quarterly report for the first quarter of 2026.

Kind regards.

Attachment

• 05-05-25 # Q1 2026 Business Review

You May Also Be Interested In

• Q1 Trading Statement 2026/27: Bang & Olufsen generated revenue growth of 2.2% in local currencies
• Egle Therapeutics Announces Positive Phase 1 Data for EGL-003, Showing Favorable Safety and Selective Treg Expansion in Healthy Volunteer Study
• Roche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis